StockOtters
Supply Chain Map
Industries
Analysis
Companies
Blog
About
🇺🇸
United States
Back to Industries
💊
Pharmaceuticals
Drug discovery, development, and manufacturing
Leaderboard
Value Chain
Leaderboard
Market Cap
Revenue
Net Profit
Net Margin %
1
Eli Lilly and Company
LLY
$962.5B
Market Cap
US
×
2
Johnson & Johnson
JNJ
$497.2B
Market Cap
US
×
3
AbbVie Inc.
ABBV
$400.7B
Market Cap
US
×
4
Merck & Co., Inc.
MRK
$254.1B
Market Cap
US
×
5
Abbott Laboratories
ABT
$218.3B
Market Cap
US
×
6
Novo Nordisk A/S
NVO
$213.8B
Market Cap
US
×
7
Amgen Inc.
AMGN
$176.3B
Market Cap
US
×
8
Gilead Sciences, Inc.
GILD
$154.2B
Market Cap
US
×
9
Pfizer Inc.
PFE
$143.3B
Market Cap
US
×
10
Sanofi
SNY
$117.4B
Market Cap
US
×
11
Vertex Pharmaceuticals Incorporated
VRTX
$117.1B
Market Cap
US
×
12
Bristol-Myers Squibb Company
BMY
$110.3B
Market Cap
US
×
13
McKesson Corporation
MCK
$102.5B
Market Cap
US
×
14
CVS Health Corporation
CVS
$98.7B
Market Cap
US
×
15
Regeneron Pharmaceuticals, Inc.
REGN
$79.3B
Market Cap
US
×
16
Cencora, Inc.
COR
$66.1B
Market Cap
US
×
17
Alnylam Pharmaceuticals, Inc.
ALNY
$52.9B
Market Cap
US
×
18
Cardinal Health, Inc.
CAH
$48.2B
Market Cap
US
×
19
Lonza Group AG
LZAGY
$47.1B
Market Cap
US
×
20
Bayer AG
BAYRY
$41.1B
Market Cap
US
×
21
IQVIA Holdings Inc.
IQV
$37.6B
Market Cap
US
×
22
AmerisourceBergen Corporation
ABC
$36.1B
Market Cap
US
×
23
Teva Pharmaceutical Industries Limited
TEVA
$34.8B
Market Cap
US
×
24
Biogen Inc.
BIIB
$25.6B
Market Cap
US
×
25
Incyte Corporation
INCY
$20.2B
Market Cap
US
×
26
Quest Diagnostics Incorporated
DGX
$19.7B
Market Cap
US
×
27
Medpace Holdings, Inc.
MEDP
$16.0B
Market Cap
US
×
28
ICON Public Limited Company
ICLR
$13.3B
Market Cap
US
×
29
Ionis Pharmaceuticals, Inc.
IONS
$12.6B
Market Cap
US
×
30
Exelixis, Inc.
EXEL
$11.9B
Market Cap
US
×
31
Dr. Reddy's Laboratories Limited
RDY
$11.8B
Market Cap
US
×
32
BioMarin Pharmaceutical Inc.
BMRN
$11.7B
Market Cap
US
×
33
Catalent, Inc.
CTLT
$11.5B
Market Cap
US
×
34
AptarGroup, Inc.
ATR
$8.0B
Market Cap
US
×
35
Syneos Health, Inc.
SYNH
$4.5B
Market Cap
US
×
36
Ultragenyx Pharmaceutical Inc.
RARE
$3.2B
Market Cap
US
×
37
Sarepta Therapeutics, Inc.
SRPT
$2.1B
Market Cap
US
×
38
Fortrea Holdings Inc.
FTRE
$1.6B
Market Cap
US
×
39
Emergent BioSolutions Inc.
EBS
$670.4M
Market Cap
US
×
40
Arcturus Therapeutics Holdings Inc.
ARCT
$177.1M
Market Cap
US
×
41
Lupin Limited
LUPN
-
Market Cap
US
×
42
Cambrex
CBM
-
Market Cap
US
×
43
Sun Pharmaceutical
SUNPHARMA
-
Market Cap
US
×
44
WuXi AppTec
WX
-
Market Cap
US
×
45
Piramal Enterprises
PEL
-
Market Cap
US
×
46
Aurobindo Pharma
ARBPF
-
Market Cap
US
×
Featured Companies
